Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair®), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial
S Veraldi, A Menter, M InnocentiVolume:
22
Year:
2008
Language:
english
Pages:
7
DOI:
10.1111/j.1468-3083.2007.02404.x
File:
PDF, 259 KB
english, 2008